This site is intended for Healthcare Professionals only.

Supply alert on Competact tablets withdrawn

Date:

Share post:

Community pharmacies now have sufficient stock of Competact 15mg/850mg tablets to meet normal demand, the Department of Health and Social Care (DH) has announced on Friday (May 14).

Earlier, the DH had issued a serious shortage protocol (SSP011) for the tablets, which is set to expire on Friday midnight.

From tomorrow (May 15) onwards, any prescriptions for Competact 15mg/850mg tablets must be dispensed in accordance with the prescription, and the SSP011 will no longer be valid for use, the DH said in an update to community pharmacies.

Pharmacy teams advised to submit their SSP claims using the EPS token, if dispensing systems do not support all the endorsement requirements to submit a valid claim.

If using an EPS token to submit SSP claims, remember to mark the corresponding EPS message as ‘Not Dispensed’ or ’ND’, to avoid double-claiming. “Where available, use the claim amend facility on the PMR system to rectify any incorrect EPS claims already submitted this month,” the DH added.

Any paper prescriptions or EPS tokens with SSP claims need to be placed in the red separator provided by the NHSBSA. Also, for any supplies made in accordance with SSPs, check that the correct number of patient charges are collected and declared on the end of month FP34C submission document.

Although an SSP cannot be used outside its period of validity, claims can be submitted up to three calendar months after expiry or withdrawal of the SSP.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Increase in pharmacy closure since January-April 2023: PM quizzed in the parliament

‘I care deeply about the future of community pharmacies', says the Prime Minister “There are over 10 and a...

BMI linked to work absenteeism, NHS expands obesity and type 2 diabetes programme

Wider rollout of NHS soup and shake diet to help 10,000+ with type 2 diabetes and obesity A recent...

GPhC appoints Louise Edwards as new Chief Strategy Officer

Louise will succeed Mark Voce who is taking early retirement from the GPhC’s position in July 2024 The General...

Community pharmacy patient safety group appoints new leadership

The new CPPSG's to bolster patient safety as community pharmacy expands services Jackie Giltrow and Jose Moss have been...